BIOMAT Database Logo BIOMAT Database Logo

Identification of 11-dehydrothromboxane B3 in human urine after administration of eicosapentaenoic acid. 1990

M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
Research Laboratories, Nippon Kayaku Co. Ltd., Tokyo, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane
D015118 Eicosapentaenoic Acid Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families. 5,8,11,14,17-Eicosapentaenoic Acid,Icosapent,5,8,11,14,17-Icosapentaenoic Acid,Eicosapentanoic Acid,Timnodonic Acid,omega-3-Eicosapentaenoic Acid,Acid, Eicosapentanoic,omega 3 Eicosapentaenoic Acid

Related Publications

M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
Identification of 11-dehydro-2,3-dinorthromboxane B3 in human urine based on the mass spectral properties of 11-dehydrothromboxane B3 and related compounds.
January 1995, Rapid communications in mass spectrometry : RCM,
M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine.
April 1987, Biochimica et biophysica acta,
M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
GC/MS/MS quantification of 11-dehydrothromboxane B2 in human urine.
August 1992, Prostaglandins, leukotrienes, and essential fatty acids,
M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
Microdetermination of 11-dehydrothromboxane B3 in human urine by gas chromatography--selected-ion monitoring using (18O2) analogue as an internal standard.
January 1995, Rapid communications in mass spectrometry : RCM,
M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
Gas chromatographic-mass spectrometric determination of 11-dehydrothromboxane B2 in human urine.
May 1992, Journal of chromatography,
M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
Microdetermination of 11-dehydrothromboxane B2 in human urine by gas chromatography-selected-ion monitoring.
May 1989, Journal of chromatography,
M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
Enzyme immunoassay of human plasma 11-dehydrothromboxane B2.
August 1991, Thrombosis research,
M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
Identification of budesonide metabolites in human urine after oral administration.
August 2012, Analytical and bioanalytical chemistry,
M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
Radioimmunoassay of 11-dehydrothromboxane B2.
January 1990, Methods in enzymology,
M Ishibashi, and Y Ohyama, and M Mizugaki, and N Harima
[Identification of cortisol sulfate in human urine after administration of cortisol].
September 1960, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
Copied contents to your clipboard!